AJ Medical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AJ Medical
Largest movements
- Tangible fixed assets +€35,410
new in 2025: €35,410
of which Furniture and vehicles: +€33,561
- Receivables within one year +€4,720
up €4,720 (+93.8%), from €5,030 to €9,750
- Deferred charges and accrued income -€2,302
down €2,302 (-34.0%), from €6,766 to €4,464
- Reserves +€50,452
up €50,452 (+108%), from €46,668 to €97,120
- Tax, wage and social debts -€12,309
down €12,309 (-95.8%), from €12,852 to €543
- Trade debts -€1,212
down €1,212 (-53.9%), from €2,250 to €1,037
- Gross operating margin +€12,441
up €12,441 (+20.9%), from €59,438 to €71,879
- Depreciation +€7,630
new in 2025: €7,630
- Taxes +€806
up €806 (+6.5%), from €12,309 to €13,116
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €64,770 | €101,701 | +€36,930 | +57.0% |
| Fixed assets | 21/28 | - | €35,410 | +€35,410 | |
| Tangible fixed assets | 22/27 | - | €35,410 | +€35,410 | |
| Furniture and vehicles | 24 | - | €33,561 | +€33,561 | |
| Other tangible fixed assets | 26 | - | €1,849 | +€1,849 | |
| Current assets | 29/58 | €64,770 | €66,291 | +€1,520 | +2.3% |
| Amounts receivable within one year | 40/41 | €5,030 | €9,750 | +€4,720 | +93.8% |
| Other amounts receivable | 41 | €5,030 | €9,750 | +€4,720 | +93.8% |
| Cash at bank and in hand | 54/58 | €52,974 | €52,076 | -€898 | -1.7% |
| Deferred charges and accrued income | 490/1 | €6,766 | €4,464 | -€2,302 | -34.0% |
| Total equity and liabilities | 10/49 | €64,770 | €101,701 | +€36,930 | +57.0% |
| Equity | 10/15 | €49,668 | €100,120 | +€50,452 | +102% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €46,668 | €97,120 | +€50,452 | +108% |
| Distributable reserves | 133 | €46,668 | €97,120 | +€50,452 | +108% |
| Amounts payable | 17/49 | €15,102 | €1,580 | -€13,522 | -89.5% |
| Amounts payable within one year | 42/48 | €15,102 | €1,580 | -€13,522 | -89.5% |
| Trade debts | 44 | €2,250 | €1,037 | -€1,212 | -53.9% |
| Suppliers | 440/4 | €2,250 | €1,037 | -€1,212 | -53.9% |
| Taxes, remuneration and social security | 45 | €12,852 | €543 | -€12,309 | -95.8% |
| Taxes | 450/3 | €12,852 | €543 | -€12,309 | -95.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €7,630 | +€7,630 | |
| Other operating charges | 640/8 | €428 | €540 | +€112 | +26.1% |
| Gross operating margin | 9900 | €59,438 | €71,879 | +€12,441 | +20.9% |
| Operating profit (loss) | 9901 | €59,010 | €63,708 | +€4,698 | +8.0% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €33 | €141 | +€108 | +330% |
| Recurring financial charges | 65 | €33 | €141 | +€108 | +330% |
| Profit (loss) for the period before taxes | 9903 | €58,978 | €63,567 | +€4,590 | +7.8% |
| Income taxes | 67/77 | €12,309 | €13,116 | +€806 | +6.5% |
| Profit (loss) for the period | 9904 | €46,668 | €50,452 | +€3,783 | +8.1% |
| Profit (loss) for the period to be appropriated | 9905 | €46,668 | €50,452 | +€3,783 | +8.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.